Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
Delayed Quote. Delayed Nasdaq - 12/03 04:00:00 pm
344.06 USD   +3.17%
12/03Health Care Ticks Lower As Pfizer Gains - Health Care Roundup
DJ
12/03Notable quotes from the Reuters Next conference
RE
12/03European ADRs Move Sharply Lower in Friday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Move Lower in Thursday Trading

10/21/2021 | 11:07am EST


© MT Newswires 2021
All news about BIONTECH SE
12/03Health Care Ticks Lower As Pfizer Gains - Health Care Roundup
DJ
12/03Notable quotes from the Reuters Next conference
RE
12/03European ADRs Move Sharply Lower in Friday Trading
MT
12/03BioNTech Capable of Quickly Modifying Vaccine for Omicron Variant, CEO Says
MT
12/03BioNTech CEO Expects To Modify COVID-19 Vaccine To Omicron Variant
MT
12/02WRAPUP 8-IMF chief says Omicron could dent global economic growth
RE
12/02Pfizer-BioNTech, Moderna's COVID-19 Jabs Offer Best Immunity Boost, UK Study Says
MT
12/02Wall Street ends higher in robust rebound from Omicron-driven rout
RE
12/02US Stocks Rebound Following Recent Sell-Offs as Omicron Variant Concerns Subside
MT
12/02Stocks Led Higher Midday by Financials, Energy; GlaxoSmithKline Says Sotrovimab Showed ..
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 17 474 M 19 769 M 19 769 M
Net income 2021 9 220 M 10 430 M 10 430 M
Net cash 2021 9 793 M 11 079 M 11 079 M
P/E ratio 2021 8,28x
Yield 2021 -
Capitalization 73 453 M 83 098 M 83 098 M
EV / Sales 2021 3,64x
EV / Sales 2022 3,14x
Nbr of Employees 2 800
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | BNTX | US09075V1026 | MarketScreener
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Last Close Price 304,13 €
Average target price 260,16 €
Spread / Average Target -14,5%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE310.30%83 098
GILEAD SCIENCES, INC.19.40%87 255
REGENERON PHARMACEUTICALS31.23%66 409
WUXI APPTEC CO., LTD.26.31%65 758
VERTEX PHARMACEUTICALS-13.76%51 819
BEIGENE, LTD.36.22%32 284